Natural products as novel scaffolds for the design of glycogen synthase kinase 3β inhibitors. (3rd April 2022)

• Record Type: Journal Article
• Authors: Montanari, Serena; Seidl, Claudia; Davani, Lara; Gianquinto, Eleonora; Emrichova, Eliska; Terenzi, Cristina; Andrisano, Vincenza; De Simone, Angela
• Is Part Of: Expert opinion on drug discovery. Volume 17:Number 4(2022)
• Page Start: 377
• Page End: 396
• Publication Date: 2022-04-03
• Subjects: GSK-3β -- natural scaffolds -- SAR -- inhibitors -- semisynthetic modification; 615.1
• DOI: 10.1080/17460441.2022.2043845
• Languages: English
• ISSNs: 1746-0441

Abstract

ABSTRACT: Introduction: The different and relevant roles of GSK-3 are of critical importance since they deal with development, metabolic homeostasis, cell polarity and fate, neuronal growth and differentiation as well as modulation of apoptotic potential. Given their involvement with different diseases, many investigations have been undertaken with the aim of discovering new and promising inhibitors for this target. In this context, atural products represent an invaluable source of active molecules. Areas covered: In order to overcome issues such as poor pharmacokinetic properties or efficacy, frequently associated with natural compounds, different GSK-3β inhibitors belonging to alkaloid or flavonoid classes have been subjected to structural modifications in order to obtain more potent and safer compounds. Herein, the authors report the results obtained from studies where natural compounds have been used as hits with the aim of providing new kinase inhibitors endowed with a better inhibitory profile. Expert opinion: Structurally modification of natural scaffolds is a proven approach taking advantage of their pharmacological characteristics. Indeed, whatever the strategy adopted is and, despite the limitations associated with the structural complexity of natural products, the authors recommend the use of natural scaffolds as a promising strategy for the discovery of novel and potent GSK-3β inhibitors.